Tom Nolan’s research reviews—19 November 2021
No surprises for PfizerThe phase II/III double-blind randomised controlled trial of Pfizer’s BNT162b2 vaccine in 5-11 year olds has been published in NEJM.1 It contains another classic covid…
Read Original Article: Tom Nolan’s research reviews—19 November 2021 »

